Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dragana Savic

MSc, DPhil

Novo Nordisk Postdoctoral Research Fellow

I completed a combined two-year master’s in Biomedical Engineering (Medicine and Technology) at the Technical University of Denmark and Copenhagen University. My master’s thesis research was completed at Yale University, where I studied the effects of stiffening vessels on cardiac function. After finalising my master’s thesis, I was recruited the University of California San Francisco (UCSF), where I led multicentre trials and worked on the first phase I clinical trial studying patients with liver metastasis using hyperpolarized MRI.

Following my position at UCSF, I moved to the University of Oxford to undertake my DPhil with Associate Professor Damian Tyler and Dr Lisa Heather investigating l-carnitine effects on cardiovascular diseases in type 1 diabetes using hyperpolarized MRI, biochemistry and Langendorff isolated heart perfusions.

In October 2018, I started my Novo Nordisk Fellowship with Dr Michael Pavlides, Professor Stefan Neubauer, and Professor Leanne Hodson. My project focuses on investigating different stages of NAFLD and what role L-carnitine has on fatty acids metabolism and insulin resistance in both healthy volunteers and patients. We are using advanced magnetic resonance spectroscopy before and after injection of L-carnitine as well as stable-isotope tracing to understand the metabolism of the liver and how it is affected in patients with NAFLD.

Recent publications

More publications